Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
120942434 | 12094243 | 4 | F | 20160129 | 20160727 | 20160219 | 20160729 | EXP | DE-BFARM-16046734 | DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-09413DE | BOEHRINGER INGELHEIM | 76.00 | YR | F | Y | 90.00000 | KG | 20160729 | MD | DE | DE |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
120942434 | 12094243 | 1 | PS | PRADAXA | DABIGATRAN ETEXILATE MESYLATE | 1 | Oral | 300 MG | N | 22512 | 150 | MG | BID | ||||||
120942434 | 12094243 | 2 | SS | PLAVIX | CLOPIDOGREL BISULFATE | 1 | Oral | 75 MG | N | 0 | 75 | MG | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
120942434 | 12094243 | 1 | Atrial fibrillation |
120942434 | 12094243 | 2 | Stent placement |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
120942434 | 12094243 | LT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
120942434 | 12094243 | Acute kidney injury | |
120942434 | 12094243 | Haemothorax | |
120942434 | 12094243 | Pulmonary sepsis |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
120942434 | 12094243 | 1 | 20150919 | 20160128 | 0 | |
120942434 | 12094243 | 2 | 20150918 | 20160128 | 0 |